Unlike previous onco-pig models that induced tumor driver gene expression in a non-cell type-specific manner via local adenovirus delivery28–30, our TYR enhancer/promoter-based model enables the control of oncogene expression, specifically in melanocytes. This evidence concerns the gene TYR and neoplasm.